↓ Skip to main content

Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma

Overview of attention for article published in Cochrane database of systematic reviews, December 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs
3 blogs
twitter
10 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
59 Dimensions

Readers on

mendeley
151 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Addition of intravenous beta2-agonists to inhaled beta2-agonists for acute asthma
Published in
Cochrane database of systematic reviews, December 2012
DOI 10.1002/14651858.cd010179
Pubmed ID
Authors

Andrew H Travers, Stephen J Milan, Arthur P Jones, Carlos A Camargo Jr, Brian H Rowe

Abstract

Inhaled beta-agonist therapy is central to the management of acute asthma. This review evaluates the benefit of an additional use of intravenous beta(2)-agonist agents.

Twitter Demographics

The data shown below were collected from the profiles of 10 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 151 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 1%
Denmark 1 <1%
Unknown 148 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 30 20%
Researcher 23 15%
Other 17 11%
Student > Bachelor 16 11%
Student > Postgraduate 10 7%
Other 28 19%
Unknown 27 18%
Readers by discipline Count As %
Medicine and Dentistry 78 52%
Nursing and Health Professions 10 7%
Social Sciences 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 8 5%
Agricultural and Biological Sciences 3 2%
Other 10 7%
Unknown 34 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2018.
All research outputs
#892,353
of 16,507,732 outputs
Outputs from Cochrane database of systematic reviews
#2,421
of 11,518 outputs
Outputs of similar age
#11,639
of 260,985 outputs
Outputs of similar age from Cochrane database of systematic reviews
#121
of 490 outputs
Altmetric has tracked 16,507,732 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,518 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 260,985 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 490 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.